Drug major Cipla has reported a growth of 19 per cent in consolidated net profit for the September quarter to Rs 423 crore from Rs 354 crore in the same quarter last year. The growth in the net profit was mainly attributable to the strong show in the India business aided by post-GST channel re-stocking. The consolidated net sales for the quarter came in at Rs. 4,082 crore, growing by 9 per cent f...